Showing all 7 results
Benzhexol Tablet
FreeProduct Composition & Strength
We supply this product as Uncoated Tablets. The chemical name Benzhexol and Trihexyphenidyl refer to the exact same molecule.
Active Ingredient Strength (Standard) Role Trihexyphenidyl HCl (Benzhexol) 2 mg Initial Dose / Mild EPS Trihexyphenidyl HCl (Benzhexol) 5 mg Forte / Maintenance Dose Excipients Q.S. Binder / Filler Biperiden Tablets
FreeProduct Composition & Strength
We supply this product as Tablets (usually White, scored). The 2 mg strength is the global standard for titration.
Active Ingredient Strength (Standard) Primary Role Biperiden Hydrochloride USP/BP 2 mg Standard Therapeutic Dose Excipients Q.S. Lactose Monohydrate / Maize Starch Filler / Binder Carbidopa and Levodopa Tablets
FreeProduct Composition & Strength
We supply this product as Uncoated Tablets (often scored/mottled). The ratios are designed to minimize nausea while maximizing brain dopamine levels.
Carbidopa (Anhydrous) Levodopa Ratio Primary Role 10 mg 100 mg 1:10 Low Dose Initiation 25 mg 100 mg 1:4 Standard Maintenance (Best Nausea Control) 25 mg 250 mg 1:10 High Dose / Advanced Disease Excipients Q.S. Microcrystalline Cellulose / Starch / Dye Filler / Colorant Pramipexole Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended Uncoated Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips to ensure the absolute chemical stability of the highly light-sensitive dihydrochloride monohydrate salt.
Active Ingredient Strength Primary Clinical Function Pramipexole (as Dihydrochloride Monohydrate) Ph.Eur./USP 0.125 mg Micro-Dose Standard: Mandatory initiation unit to prevent orthostatic shock, and the gold-standard maintenance dose for RLS. Pramipexole (as Dihydrochloride Monohydrate) Ph.Eur./USP 0.25 mg / 0.5 mg Titration Standard: Mid-level doses for the gradual, safe escalation of Parkinson’s therapy. Pramipexole (as Dihydrochloride Monohydrate) Ph.Eur./USP 1 mg Advanced PD Standard: High-dose maintenance therapy for severe, refractory Parkinson’s Disease. Excipients Mannitol / Maize Starch / Povidone K25 / Colloidal Silicon Dioxide / Magnesium Stearate Diluent / Binder / Glidant / Lubricant (Engineered for immediate gastric dissolution and rapid, highly predictable systemic absorption) *Pack Sizes: 10×10 Alu-Alu Blisters or 3×10 Unit-Dose Blisters (Optimized specifically for strict, high-compliance chronic neurology dispensing and complex titration regimens).
Rasagiline Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended Uncoated or Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips to ensure the absolute chemical stability of the highly sensitive mesylate salt.
Active Ingredient Strength Primary Clinical Function Rasagiline Mesylate INN/Ph.Eur. 0.5 mg (Base Equivalent) Adjunct Standard: Initiating dose when used in combination with Levodopa. Rasagiline Mesylate INN/Ph.Eur. 1 mg (Base Equivalent) Global Clinical Standard: Maximum daily dose for monotherapy or advanced adjunct therapy. Excipients Mannitol / Maize Starch / Pregelatinized Starch / Colloidal Silicon Dioxide / Stearic Acid Diluent / Binder / Superdisintegrant / Glidant (Engineered for immediate gastric dissolution and rapid crossing of the blood-brain barrier) *Pack Sizes: 10×10 Alu-Alu Blisters or 3×10 Unit-Dose Blisters (Optimized specifically for strict high-compliance 30-day chronic neurology dispensing regimens).
Ropinirole Extended-Release
FreeProduct Composition & Strength
We supply this product as a Precision-Engineered Polymeric Matrix Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips or heavy-gauge HDPE bottles to ensure the absolute stability of the modified-release polymers.
Active Ingredient Strength Primary Clinical Function Ropinirole HCl USP/Ph.Eur. 2 mg / 4 mg Base titration units for the slow, safe initiation of dopaminergic therapy. Ropinirole HCl USP/Ph.Eur. 8 mg Global Clinical Standard: Advanced maintenance dose for 24-hour continuous symptom control. (Higher total daily doses may be required). Excipients Hypromellose (HPMC) / Carmellose Sodium / Lactose Monohydrate / Magnesium Stearate Hydrophilic Polymer Matrix / Diluent / Lubricant (Engineered to form a viscous gel layer that controls the strict 24-hour drug diffusion rate) *Pack Sizes: 10×10 Alu-Alu Blisters or Bottles of 28/30 (Optimized specifically for strict 30-day chronic neurology dispensing regimens).
Trihexyphenidyl Tablet
FreeProduct Composition & Strength
We supply this product as Uncoated Tablets. The tablets are often scored to allow for precise titration.
Active Ingredient Strength (Standard) Role Trihexyphenidyl HCl USP/BP 2 mg Initial Dose / EPS Prophylaxis Trihexyphenidyl HCl USP/BP 5 mg Maintenance Dose / High Potency Excipients Q.S. Binder / Filler
